These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 35069702)
1. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer. Cheng T; Chen P; Chen J; Deng Y; Huang C Front Genet; 2021; 12():809600. PubMed ID: 35069702 [TBL] [Abstract][Full Text] [Related]
2. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma. Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer. Yu J; He Z; He X; Luo Z; Lian L; Wu B; Lan P; Chen H Front Oncol; 2021; 11():771099. PubMed ID: 34804973 [TBL] [Abstract][Full Text] [Related]
4. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential. Gobin E; Bagwell K; Wagner J; Mysona D; Sandirasegarane S; Smith N; Bai S; Sharma A; Schleifer R; She JX BMC Cancer; 2019 Jun; 19(1):581. PubMed ID: 31200666 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma. Xu L; Yang H; Yan M; Li W Clin Exp Med; 2023 Oct; 23(6):2065-2083. PubMed ID: 36169759 [TBL] [Abstract][Full Text] [Related]
6. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma. Wang T; Zhang Y; Bai J; Xue Y; Peng Q BMC Cancer; 2021 Sep; 21(1):1068. PubMed ID: 34587931 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer. Luan H; Jian L; Huang Y; Guo Y; Zhou L Sci Rep; 2023 Oct; 13(1):17211. PubMed ID: 37821678 [TBL] [Abstract][Full Text] [Related]
8. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC). Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase 14 and 19 expression is associated with thoracic aortic aneurysms. Jackson V; Olsson T; Kurtovic S; Folkersen L; Paloschi V; Wågsäter D; Franco-Cereceda A; Eriksson P J Thorac Cardiovasc Surg; 2012 Aug; 144(2):459-66. PubMed ID: 21955474 [TBL] [Abstract][Full Text] [Related]
10. Mining the prognostic significance and immune infiltration of Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108 [TBL] [Abstract][Full Text] [Related]
11. Abnormal Hypermethylation of CpG Dinucleotides in Promoter Regions of Matrix Metalloproteinases Genes in Breast Cancer and Its Relation to Epigenomic Subtypes and HER2 Overexpression. Simonova OA; Kuznetsova EB; Tanas AS; Rudenko VV; Poddubskaya EV; Kekeeva TV; Trotsenko ID; Larin SS; Kutsev SI; Zaletaev DV; Nemtsova MV; Strelnikov VV Biomedicines; 2020 May; 8(5):. PubMed ID: 32397602 [TBL] [Abstract][Full Text] [Related]
12. New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells. Delassus GS; Cho H; Eliceiri GL J Cell Physiol; 2011 Dec; 226(12):3378-84. PubMed ID: 21344390 [TBL] [Abstract][Full Text] [Related]
13. An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer. Xia H; Yu W; Liu M; Li H; Pang W; Wang L; Zhang Y Oncol Lett; 2019 Sep; 18(3):2985-2994. PubMed ID: 31452777 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer. Geng X; Chen C; Huang Y; Hou J Int J Med Sci; 2020; 17(11):1550-1560. PubMed ID: 32669958 [No Abstract] [Full Text] [Related]
15. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722 [TBL] [Abstract][Full Text] [Related]
16. Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma. Xie J; Zhou X; Wang R; Zhao J; Tang J; Zhang Q; Du Y; Pang Y Medicine (Baltimore); 2021 Jun; 100(23):e26135. PubMed ID: 34114996 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of MMPs in Corneas Requiring Penetrating and Deep Anterior Lamellar Keratoplasty. Wolf M; Clay SM; Oldenburg CE; Rose-Nussbaumer J; Hwang DG; Chan MF Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1734-1747. PubMed ID: 31022731 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study. Pietruszewska W; Bojanowska-Poźniak K; Kobos J Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931 [TBL] [Abstract][Full Text] [Related]
19. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer. Li D; Zhao W; Zhang X; Lv H; Li C; Sun L Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208 [TBL] [Abstract][Full Text] [Related]
20. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support. Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]